Skip to main content

Table 3 Parkinson’s disease, RBD and control case information from ante-mortem CSF and serum received from OPDC

From: Reduced sphingolipid hydrolase activities, substrate accumulation and ganglioside decline in Parkinson’s disease

 

Control subjects

PD subjects

RBD subjects

Cohort size

15

30

30

Female (%)

53.3

50.0

13.3

Male (%)

46.7

50.0

86.7

Age (years)

66.2 ± 8.4

63.8 ± 9.9

64.4 ± 11.6

H&Y score

N/A

Score 1: n = 6

Score 2: n = 21

Score 3: n = 3

N/A

  1. RBD REM sleep behaviour disorder. Only serum was available for RBD cases. Data summarised as mean ± SD
Back to article page

Molecular Neurodegeneration

ISSN: 1750-1326